Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MDB vs MRNA✓SelectedUSD · MRNAMDB vs MRNA performance historyLatest closeAs of-5.77%11/17
Stock and ETF performance explorer

MDB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+254.0%
MRNA return
+840.0%
Excess return
-586.0%
Maximum drawdown
-76.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-5.8%-3.9%-1.8%-5.3%
7D-10.0%-17.6%+7.5%-8.1%
30D-11.5%-5.1%-6.4%-11.2%
3M-31.9%+220.8%-252.7%-46.1%
6M-4.3%+321.7%-326.0%-28.7%
YTD-28.8%+601.3%-630.1%-52.7%
1Y-12.1%+735.2%-747.3%-43.7%
3Y-23.9%+170.5%-194.5%-43.4%
5Y-47.6%-14.6%-33.0%-54.3%
All+254.0%+840.0%-586.0%+148.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling